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these ticks suggest that human habita-
tion near bats and their associated tick 
colonies could pose a public health 
risk. Growth in laboratory animals or 
culture could help isolate these novel 
organisms for further studies to estab-
lish the distribution and public health 
implications of this newly identifi ed 
Borrelia sp.
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KI and WU 
Polyomaviruses in 
Children, France 
To the Editor: Two new mem-
bers of the Polyomaviridae family, 
provisionally named Karolinska In-
stitutet virus (KIPyV) and Washing-
ton University virus (WUPyV), have 
been recently discovered (1,2). These 
new polyomaviruses were identifi ed 
by screening human respiratory se-
cretions with molecular tools. KIPyV 
and WUPyV are genetically related to 
the BK virus and the JC virus, the 2 
known members of the family Poly-
omaviridae that affect humans.
In France, from November 2006 
through June 2007, nasopharyngeal 
aspirates were obtained from 537 chil-
dren who were <5 years of age and 
who had acute respiratory tract disease. 
The aspirates were tested for respira-
tory syncytial virus (RSV); infl uenza 
virus types A and B; parainfl uenza vi-
rus types 1, 2, and 3; and adenoviruses 
(AdVs) by direct immunofl uorescence 
assay. The aspirates were also tested 
for human metapneumovirus (HMPV) 
by an enzyme immunoassay (HMPV 
EIA, Biotrin, Lyon, France) and for 
the human bocavirus (HBoV) by PCR 
(3). Samples were placed on MRC5 
cell monolayers for virus isolation.
Nucleic acid extracts were tested 
for KIPyV and WUPyV DNA by PCR. 
KIPyV detection was performed by us-
ing a nested PCR approach that target-
ed the VP1 capsid gene as described 
by Allander et al. (1). For WUPyV 
detection, primers targeted the pre-
dicted 3′ end of the large T antigen 
coding region as described by Gaynor 
et al. (2). The amplifi cation specifi city 
was assessed by sequencing the PCR 
product; sequences were deposited in 
GenBank (WUPyV isolates, accession 
no. AM778536–48; KIPyV isolates, 
accession no. AM849808–10).
At least 1 type of virus was identi-
fi ed for 271 (50.5%) children. The vi-
ruses found were RSVs in 175 (32.6%), 
HBoVs in 54 (10.0%), HMPVs in 50 
(9.3%), rhinoviruses/enteroviruses in 
11 (2%), infl uenza A viruses in 8 
(1.5%), human AdVs in 6 (1.1%), 
and parainfl uenza type 3 viruses in 4 
(0.7%) samples. Aspirates were not 
tested for coronaviruses; detection of 
rhinoviruses/enteroviruses was likely 
low because cell culture is less sensi-
tive than molecular assays.
A total of 13 (2.4%) samples 
were positive for WUPyV; of these 4 
(30.8%) were co-infected with another 
virus. The 13 children with samples 
positive for WUPyV had a median age 
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of 11.2 (2–48) months and the male/
female sex ratio was 2.2. KIPyV DNA 
was detected in samples from 3 (0.6%) 
boys (ages 10, 18 and 30 months); 1 
of those samples was co-infected with 
RSV and HMPV.
Sequences of WUPyV and KIPyV 
isolates varied little from each other 
and from other GenBank sequences, 
which suggests that these polyomavi-
ruses are genetically conserved virus-
es. Clinical characteristics of children 
infected with WUPyV and KIPyV are 
retrospectively recorded (Table). All 
children recovered and were able to 
return home within 1 to 10 days, with 
the exception of 1 child. This child 
had been hospitalized since birth for 
congenital myopathy; nosocomial ac-
quisition or vertical transmission of 
the WUPyV is suspected.
Our data are in agreement with 
the 2 original reports that show that the 
new KI and WU polyomaviruses may 
be detected in respiratory secretions 
from patients with respiratory diseases 
(1,2). WUPyV was detected in 2.4% 
of children <5 years of age who were 
hospitalized with respiratory tract dis-
ease, which is in accordance with the 
2% incidence reported by Gaynor et 
al. (2). The 0.6% prevalence observed 
for KIPyV PCR is also in agreement 
with data reported from Sweden (1) 
and Australia (4). A seasonal change 
in the presence of WUPyV was not 
observed; however, all KIPyV isolates 
were found only during January.
KIPyV and WUPyV were mainly 
detected in samples from children with 
lower respiratory tract disease, such as 
bronchiolitis or atypical pneumonia, 
and in samples from children with ex-
acerbated asthma. These preliminary 
data on the likely role of these viruses 
as respiratory pathogens need to be 
interpreted with caution. Aspirates 
were obtained only from those with 
observed symptoms; no asymptom-
atic controls were tested. Detection 
of WUPyV and KIPyV in respiratory 
samples may simply refl ect a respira-
tory transmission route as previously 
suggested for BK virus and JC virus 
(5). Another virus was in aspirates 
from 31% of the children with KI and 
WU polyomaviruses. Substantial rates 
of codetection were also reported in 
the initial descriptions of both WUPyV 
and KIPyV (1,2). More recently, Bial-
asiewicz et al. reported a 25% rate of 
codetection of KIPyV with another 
pathogen (4). These high rates of co-
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Table. Clinical findings for 13 children infected with WU polyomavirus and 3 children infected with KI polyomavirus* 
Sex/age,
mo Copathogen 
Fever, 
°C
CRP,
mg/L
SaO2,
%
WBC, x 103
cells/μL
Chest radiograph 
findings Diagnosis
Clinical signs and 
symptoms 
WU polyomavirus 
 M/2 – 37.9 8.3 NA 9.4 Hyperinflation Pneumonia Cough, dyspnea 
 M/12 – 39.2 112.0 NA 18.2 Hyperinflation, 
interstitial infiltrate 
Bronchiolitis Cough, dyspnea 
 F/20 – 38.7 56.0 NA 13.7 Hyperinflation Atypical 
pneumonia
Cough, respiratory 
distress, diarrhea 
 F/12 – 37.8 15.0 96 12.3 Hyperinflation Bronchiolitis Cough, dyspnea,  
pharyngitis 
 M/10 – 39.0 90.3 NA 18.0 Normal Idiopathic
fever
Fever 
 F/14 – 38.9 20.8 95 11.0 Hyperinflation, 
interstitial infiltrate 
Atypical 
pneumonia
Cough, wheezing, 
dyspnea 
 F/10 RSV 38.0 14.0 NA 17.2 Hyperinflation, 
interstitial infiltrate 
Bronchiolitis Cough, respiratory 
distress, dyspnea 
 M/6 RSV 38.0 NA 89 NA Hyperinflation Bronchiolitis Respiratory distress, 
wheezing 
 M/48 HMPV 36.8 15.0 94 13.0 Hyperinflation Asthma Cough, respiratory 
distress 
 M/24 – 37.0 23.0 98 13.9 Hyperinflation Asthma Cough, respiratory 
distress 
 M/2 – 38.5 38.5 70 16.0 Normal Idiopathic
fever
Cough, fever 
 M/11 HBoV 39.0 5.5 94 6.2 Interstitial infiltrate Atypical 
pneumonia
Cough, fever 
 M/10 – 37.0 10.0 97 18.0 Alveolar syndrome Congenital
myopathy 
Respiratory distress
KI polyomavirus 
 M/10 RSV, HMPV 39.0 NA NA NA Hyperinflation Bronchiolitis Cough, wheezing, 
otitis, diarrhea 
 M/30 – 39.2 <5.0 NA 11.0 Interstitial infiltrate Influenza-like
pneumonia
Cough, dyspnea, 
otitis, sore throat 
 M/18 – 38.9 23.0 96 14.8 Hyperinflation, 
atelectasis
Asthma Cough, dyspnea, 
wheezing 
*CRP, C-reactive protein; SaO2, oxygen saturation; WBC, white blood cells; NA, not available; HMPV, human metapneumovirus; RSV, respiratory 
syncytial virus; HBoV, human bocavirus. 
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infection raise questions about the real 
pathogenic role of these viruses.
As with other polyomaviruses, 
WUPyV and KIPyV could establish 
persistent and latent infections with 
likely asymptomatic reactivations (5), 
and detection of these viruses could 
also refl ect a long-term shedding from 
previous acute episode. Recently pub-
lished studies have not shown a patho-
genic role for these new polyomavi-
ruses in respiratory tract disease (6,7); 
however, more comprehensive studies 
are needed to elucidate whether both 
KIPyV and WUPyV have any clinical 
relevance.
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Milk Replacers and 
Bovine Spongiform 
Encephalopathy in 
Calves, Japan
To the Editor: Milk replacers 
produced from a specifi c feed factory 
in Japan were suspected of being asso-
ciated with a cluster of bovine spongi-
form encephalopathy (BSE) infection 
in calves. We conducted a case–con-
trol study to test this association. 
In Japan, BSE infection has been 
confi rmed in 32 calves as of the end 
of May 2007; 13 of these calves were 
born between December 1995 and 
August 1996. One BSE-infected calf 
was born in 1992 and had an atypical 
BSE phenotype (1). Because no BSE-
infected calves were born in 1997 and 
1998, we considered that those born 
in 1995 and 1996 formed an indepen-
dent temporal cluster (Figure). Epi-
demiologic investigation showed that 
all 13 calves were fed milk replacers 
produced by a specifi c factory. Ten 
calves were born in Hokkaido, and 3 
were born in the Kanto region, which 
is ≈800 km away from Hokkaido.
In the case–control study, all farms 
where the 13 BSE-infected calves were 
born and raised for at least 1 year were 
defi ned as case farms. Control farms 
were defi ned as dairy farms where no 
BSE calves had been reported. Candi-
dates for control farms comprised 200 
randomly selected farms, which were 
located in 23 prefectures where the 
milk replacers were distributed. We 
used a national cattle identifi cation 
database for random selection. Vet-
erinary offi cers from the local govern-
ment interviewed farmers in Novem-
ber and December 2006 and requested 
that they complete a questionnaire on 
farming practices in 1996, including 
herd size and use of milk replacers and 
calf concentrates. For the case farms, 
information previously obtained from 
outbreaks was used. Of the 200 po-
tential control farms, 154 farms were 
used as controls. Forty-six farms were 
excluded; 24 farmers did not respond 
or could not specify the use of milk 
replacers; and 22 farms had either 
closed or farmers did not respond for 
miscellaneous reasons.   
Among the 154 control farms, 
36 farms (23%) used the milk replac-
ers from the specifi c factory, 89 farms 
(58%) used other milk replacers, and 
29 farms (19%) did not use milk re-
placers. Since 1 case farm lacked 
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Figure. Number of cases of bovine spongiform encephalopathy by calves’ birth year, Japan. 
